首页> 外文期刊>Journal of Hepatology: The Journal of the European Association for the Study of the Liver >Features of the CD4(+) T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels.
【24h】

Features of the CD4(+) T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels.

机译:丙型肝炎病毒感染且丙氨酸氨基转移酶水平持续正常和异常的肝和外周血中CD4(+)T细胞反应的特征。

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Aims: The liver is the primary site of hepatitis C virus (HCV) replication; intrahepatic T-cell responses may influence liver disease severity.Methods: HCV-specific CD4(+) T-cell reactivity was investigated ex vivo in paired liver tissue and peripheral blood from 42 chronic HCV patients.Results: The frequencies with which HCV-specific HLA class-II-restricted CD4(+) T-cell proliferation were observed were 29% in liver and 36% in peripheral blood. Among responses, non-structural-3 protein (NS3)-specific T-cell proliferation was dominant but non-exclusive and did rarely occur concurrently in liver infiltrate and peripheral blood suggesting liver compartmentalization of a CD4(+) T-cells population. Compared with 24 patients with abnormal ALT levels, 18 HCV carriers with persistently normal ALT levels had similar serum and liver viral loads but showed: (i) a low-activity grade and stage chronic hepatitis (P<0.001); (ii) less intrahepatic CD4(+) T-lymphocytes (P<0.01); (iii) less frequent intrahepatic (17 vs. 33%) and peripheral (17 vs. 38%) NS3-specific CD4(+) T-cell proliferation; (iv) less often in vitro T-helper (Th)1 (interferon-gamma) cytokine production (2 vs. 18%; P<0.001).Conclusions: Our data show a low frequency of intrahepatic HCV-specific HLA class-II-restricted CD4(+) Th1 responses in patients with chronic HCV. However, these Th1 responses are detected more often in those patients with overt clinical and histological disease.
机译:背景/目的:肝脏是丙型肝炎病毒(HCV)复制的主要部位。方法:对42例慢性HCV患者的配对肝组织和外周血中HCV特异性CD4(+)T细胞反应性进行了离体研究。结果:HCV特异性的频率HLA II类限制的CD4(+)T细胞增殖在肝脏中占29%,在外周血中占36%。在响应中,非结构性3蛋白(NS3)特异性T细胞增殖占主导地位,但不是排他性的,并且很少在肝浸润液和外周血中同时发生,提示CD4(+)T细胞群体的肝区室化。与24例ALT水平异常的患者相比,18例ALT水平持续正常的HCV携带者具有相似的血清和肝病毒载量,但显示: (ii)肝内CD4(+)T淋巴细胞较少(P <0.01); (iii)较少的肝内NS3特异性CD4(+)T细胞增殖(17%vs. 33%)和外周(17%vs. 38%); (iv)较少产生体外T辅助(Th)1(干扰素-γ)细胞因子(2比18%; P <0.001)。结论:我们的数据显示,肝内HCV特异性II类HLA发生率较低慢性HCV患者体内的CD4(+)Th1限制性反应。但是,这些Th1反应在那些明显的临床和组织学疾病患者中更常见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号